Bone Metastases Clinical Trials

A listing of Bone Metastases medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Phoenix Arizona 85004

Patients are needed to participate in a clinical research study evaluating LHRH agonist/antagonist, Bicalutamide and Radium-223 dichloride for the treatment of Prostate Cancer, Bone Metastases or Prostate Neoplasms

Scottsdale Arizona 85252

A clinical trial to evaluate treatments using Bone Scan: F18-Fluoride PET/CT or TC-MDP for patients with Bone Metastases

California

Duarte California 91010

A clinical trial seeking patients for a research study for the treatment of Bone Metastases

Los Angeles California 90095

A clinical trial to evaluate treatments using Bone Scan: F18-Fluoride PET/CT or TC-MDP for patients with Bone Metastases

Los Angeles California 90073

A clinical trial to evaluate treatments using Bone Scan: F18-Fluoride PET/CT or TC-MDP for patients with Bone Metastases

Stanford California 94305

A clinical trial seeking patients for a research study for the treatment of Bone Metastases

Stanford California 94305

A clinical trial to evaluate treatments using Bone Scan: F18-Fluoride PET/CT or TC-MDP for patients with Bone Metastases

Georgia

Savannah Georgia 31406

A clinical trial to evaluate treatments using Bone Scan: F18-Fluoride PET/CT or TC-MDP for patients with Bone Metastases

Illinois

Peoria Illinois 61615

Patients are needed to participate in a clinical research study evaluating LHRH agonist/antagonist, Bicalutamide and Radium-223 dichloride for the treatment of Prostate Cancer, Bone Metastases or Prostate Neoplasms

Indiana

Indianapolis Indiana 46202

Patients are needed to participate in a clinical research study evaluating LHRH agonist/antagonist, Bicalutamide and Radium-223 dichloride for the treatment of Prostate Cancer, Bone Metastases or Prostate Neoplasms

Indianapolis Indiana 46219

Patients are needed to participate in a clinical research study evaluating LHRH agonist/antagonist, Bicalutamide and Radium-223 dichloride for the treatment of Prostate Cancer, Bone Metastases or Prostate Neoplasms

Iowa

Iowa City Iowa 52242

Patients are needed to participate in a clinical research study evaluating LHRH agonist/antagonist, Bicalutamide and Radium-223 dichloride for the treatment of Prostate Cancer, Bone Metastases or Prostate Neoplasms

Michigan

Ann Arbor Michigan 48109

A clinical trial to evaluate treatments using Bone Scan: F18-Fluoride PET/CT or TC-MDP for patients with Bone Metastases

Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study evaluating LHRH agonist/antagonist, Bicalutamide and Radium-223 dichloride for the treatment of Prostate Cancer, Bone Metastases or Prostate Neoplasms

Detroit Michigan 48202

Patients are needed to participate in a clinical research study evaluating LHRH agonist/antagonist, Bicalutamide and Radium-223 dichloride for the treatment of Prostate Cancer, Bone Metastases or Prostate Neoplasms

Wyoming Michigan 49519

Patients are needed to participate in a clinical research study evaluating LHRH agonist/antagonist, Bicalutamide and Radium-223 dichloride for the treatment of Prostate Cancer, Bone Metastases or Prostate Neoplasms

Missouri

Kansas City Missouri 64111

A clinical trial to evaluate treatments using Bone Scan: F18-Fluoride PET/CT or TC-MDP for patients with Bone Metastases

St. Louis Missouri 63106

A clinical trial to evaluate treatments using Bone Scan: F18-Fluoride PET/CT or TC-MDP for patients with Bone Metastases

St. Louis Missouri 63110

A clinical trial to evaluate treatments using Bone Scan: F18-Fluoride PET/CT or TC-MDP for patients with Bone Metastases

Nebraska

Omaha Nebraska 68130

Patients are needed to participate in a clinical research study evaluating LHRH agonist/antagonist, Bicalutamide and Radium-223 dichloride for the treatment of Prostate Cancer, Bone Metastases or Prostate Neoplasms

New Hampshire

Lebanon New Hampshire 03756

A clinical trial to evaluate treatments using Bone Scan: F18-Fluoride PET/CT or TC-MDP for patients with Bone Metastases

New York

Lake Success New York 11042

Patients are needed to participate in a clinical research study evaluating LHRH agonist/antagonist, Bicalutamide and Radium-223 dichloride for the treatment of Prostate Cancer, Bone Metastases or Prostate Neoplasms

New York New York 10065

A clinical trial to evaluate treatments using Bone Scan: F18-Fluoride PET/CT or TC-MDP for patients with Bone Metastases

Pennsylvania

Philadelphia Pennsylvania

A clinical research study of [68Ga]P15-041 for the treatment of Prostate Cancer or Bone Metastases

Rhode Island

Providence Rhode Island 02903

A Phase 2 clinical study for patients with Non Small Cell Lung Cancer With Bone Metastatses

Texas

Galveston Texas 77555

Patients are needed to participate in a clinical research study evaluating LHRH agonist/antagonist, Bicalutamide and Radium-223 dichloride for the treatment of Prostate Cancer, Bone Metastases or Prostate Neoplasms

Houston Texas 77030

A clinical trial to evaluate treatments using Bone Scan: F18-Fluoride PET/CT or TC-MDP for patients with Bone Metastases

Utah

Salt Lake City Utah 84112

A clinical trial to evaluate treatments using Bone Scan: F18-Fluoride PET/CT or TC-MDP for patients with Bone Metastases

Wisconsin

Milwaukee Wisconsin 53295

Patients are needed to participate in a clinical research study evaluating LHRH agonist/antagonist, Bicalutamide and Radium-223 dichloride for the treatment of Prostate Cancer, Bone Metastases or Prostate Neoplasms

Australia

Melbourne Victoria 8006

A clinical trial to evaluate treatments using Bone Scan: F18-Fluoride PET/CT or TC-MDP for patients with Bone Metastases

Austria

Linz

A clinical trial to evaluate treatments using Bone Scan: F18-Fluoride PET/CT or TC-MDP for patients with Bone Metastases

Germany

Many locations

A clinical trial seeking patients for a research study for the treatment of Castration-Resistant Prostate Cancer

Multiple sites

A clinical trial to evaluate treatments for patients with Breast Cancer, Prostate Cancer or Bone Metastases

Israel

Ramat Gan

A clinical research study of Exablate treatment and Radiation for the treatment of Bone Cancer, Bone Metastases or Pain

Japan

Osaka 545-8585

A clinical trial to evaluate treatments using Ra-223 in combination with enzalutamide for patients with Castration-resistant Prostate Cancer or Bone Metastases

Netherlands

Alkmaar

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride for the treatment of Prostate Cancer Metastatic or Bone Metastases

Almelo

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride for the treatment of Prostate Cancer Metastatic or Bone Metastases

Amersfoort Utrecht 3818 ES

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride for the treatment of Prostate Cancer Metastatic or Bone Metastases

Amsterdam 1066CX

Patients are needed to participate in a clinical research study evaluating Blood tests for the treatment of Prostate Cancer Metastatic or Bone Metastases

Amsterdam 1066CX

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride for the treatment of Prostate Cancer Metastatic or Bone Metastases

View More ▼

Arnhem

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride for the treatment of Prostate Cancer Metastatic or Bone Metastases

Breda

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride for the treatment of Prostate Cancer Metastatic or Bone Metastases

Delft

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride for the treatment of Prostate Cancer Metastatic or Bone Metastases

Deventer

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride for the treatment of Prostate Cancer Metastatic or Bone Metastases

Eindhoven

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride for the treatment of Prostate Cancer Metastatic or Bone Metastases

Gouda

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride for the treatment of Prostate Cancer Metastatic or Bone Metastases

Groningen

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride for the treatment of Prostate Cancer Metastatic or Bone Metastases

Heerlen 6401 CX

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride for the treatment of Prostate Cancer Metastatic or Bone Metastases

Hoofddorp

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride for the treatment of Prostate Cancer Metastatic or Bone Metastases

Nieuwegein

Patients are needed to participate in a clinical research study evaluating Radium-223 dichloride for the treatment of Prostate Cancer Metastatic or Bone Metastases